Evidence map›Paper›PMID 15750110›Full record

ArticleJournal of clinical microbiology2005

Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal.

J Schachter, E W Hook, D H Martin, D Willis, P Fine, D Fuller, J Jordan, W M Janda, M Chernesky

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00618449 (Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00618449 phase4completednot on this mapstarted 2008, after this paper: background citation

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

TypeinterventionalSponsorUniversity of California, San FranciscoRan2008 to 2009Enrolled1,139ConditionsTrachoma, Chlamydia TrachomatisArmsAzithromcyin, Azithromycin
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Trial
  4. Laboratory detection methods for Chlamydia trachomatis infection in children: a review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  5. ExploringFrontiers in public health · 2025
    Article
  6. Article
  7. Chlamydia trachomatis IgG3 seropositivity is associated with gastroschisis.Journal of perinatology : official journal of the California Perinatal Association · 2015
    Article
  8. Review
  9. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2014
    Article
  10. Article
  11. Article
  12. Genital Chlamydia trachomatis: an update.The Indian journal of medical research · 2013
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Antibiotic resistance in Chlamydiae.Future microbiology · 2010
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J SchachterChlamydia Research Laboratory, Department of Laboratory Medicine, University of California-San Francisco, 1001 Potrero Ave., SFGH 3416, San Francisco, CA 94110, USA. jsch@itsa.ucsf.edu
E W Hook
D H Martin
D Willis
P Fine
D Fuller
J Jordan
W M Janda
M Chernesky

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Centers for Disease Control and Prevention recommended confirming positive screening tests for Chlamydia trachomatis when positive predictive values are <90%. It is accepted that less sensitive tests (i.e., culture and immunoassays) should not be used to confirm the results of more sensitive nucleic acid amplification tests (NAATs). We show that the same principle applies when NAATs are used for confirmation.

Indexed as

Nucleic Acid Amplification TechniquesCenters for Disease Control and Prevention, U.S.Chlamydia trachomatisFemaleHumansMaleSensitivity and SpecificityUnited States

Identifiers

PMID15750110
PMCPMC1081269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.